Study ATG115317, a Comparison of Atorvastatin and Glimepiride Fixed Dose Combination and Atorvastatin and Glimepiride Loose Combination in the Treatment of Patients With Type 2 Diabetes Mellitus
Phase of Trial: Phase III
Latest Information Update: 03 Dec 2015
At a glance
- Drugs Atorvastatin/glimepiride (Primary) ; Atorvastatin; Glimepiride
- Indications Hypercholesterolaemia; Type 2 diabetes mellitus
- Focus Registrational; Therapeutic Use
- Sponsors GlaxoSmithKline
- 10 Jun 2017 Biomarkers information updated
- 31 May 2013 Planned end date changed from 1 Jun 2013 to 1 Sep 2013 as reported by ClinicalTrials.gov.
- 31 May 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.